NO920315D0 - USE OF NADH AND NADPH AS ENERGY REPLACEMENT PRODUCTS - Google Patents
USE OF NADH AND NADPH AS ENERGY REPLACEMENT PRODUCTSInfo
- Publication number
- NO920315D0 NO920315D0 NO920315A NO920315A NO920315D0 NO 920315 D0 NO920315 D0 NO 920315D0 NO 920315 A NO920315 A NO 920315A NO 920315 A NO920315 A NO 920315A NO 920315 D0 NO920315 D0 NO 920315D0
- Authority
- NO
- Norway
- Prior art keywords
- nadh
- nadph
- replacement products
- energy replacement
- reduced form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Detergent Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Dental Preparations (AREA)
- Fodder In General (AREA)
- Non-Alcoholic Beverages (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Use is described of nicotinamide adenine dinucleotide in its reduced form (NADH) and/or nicotinamide adenine dinucleotide phosphate in its reduced form (NADPH) and/or a physiologically tolerated salt of the same for energy substitution in humans or animals, as is a foodstuff or confectionary product for human consumption or a feedstuff for animal consumption having a content of the substances mentioned.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4102240A DE4102240C1 (en) | 1991-01-24 | 1991-01-24 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO920315D0 true NO920315D0 (en) | 1992-01-23 |
NO920315L NO920315L (en) | 1992-07-27 |
NO304672B1 NO304672B1 (en) | 1999-02-01 |
Family
ID=6423720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO920315A NO304672B1 (en) | 1991-01-24 | 1992-01-23 | Use of NADH and NADPH as energy replacement products |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0496479B1 (en) |
JP (1) | JP2533709B2 (en) |
AT (1) | ATE112664T1 (en) |
AU (1) | AU663479B2 (en) |
BR (1) | BR9200207A (en) |
CA (1) | CA2059510C (en) |
DE (2) | DE4102240C1 (en) |
DK (1) | DK0496479T3 (en) |
ES (1) | ES2061313T3 (en) |
FI (1) | FI920323A (en) |
HU (1) | HU9200213D0 (en) |
IE (1) | IE69861B1 (en) |
NO (1) | NO304672B1 (en) |
ZA (1) | ZA92275B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2735293A1 (en) * | 1995-01-17 | 1996-07-18 | Menuco Corp. | Nadh and nadph therapeutic agents for dermal administration |
US5712259A (en) * | 1996-04-22 | 1998-01-27 | Birkmayer Pharmaceuticals | NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome |
US5668114A (en) * | 1996-05-08 | 1997-09-16 | Birkmayer Pharmaceuticals | NADH and NADPH pharmaceuticals for treating hypertension |
IT1318565B1 (en) * | 2000-06-09 | 2003-08-27 | World Pharma Tech Ltd | NADH OCTOCOSANOL EVITAMIN E PROENERGETIC FOOD SUPPLEMENT |
US20040126751A1 (en) * | 2002-12-27 | 2004-07-01 | Birkmayer Jorg G.D. | Method of prolonging the life-span of living cells using NADH, NADPH and ADP-ribose |
DE102008010245B4 (en) * | 2008-02-20 | 2011-02-10 | Emag Holding Gmbh | Method for grinding wavy workpieces |
DE102014103443A1 (en) * | 2014-03-13 | 2015-09-17 | Jürgen Ruhlmann | Composition for use in the treatment of fatigue, lack of concentration, withdrawal symptoms, headaches and colds, in particular loss of power, hangover and fatigue |
KR102306818B1 (en) * | 2018-07-26 | 2021-09-30 | 오리진 바이오테크놀로지 가부시키가이샤 | Functional eggs and their production method |
DE202022000567U1 (en) | 2022-03-06 | 2022-03-16 | Penta Phi Eg | Liposomal formulation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3594475A (en) * | 1968-04-24 | 1971-07-20 | Kyowa Hakko Kogyo Kk | Method of treating and preventing the side effects of antibiotics |
DE3380342D1 (en) * | 1982-10-26 | 1989-09-14 | Cta Finanz Ag | Device and process for optimising the tissue mass of organs within the genetic fluctuation range in humans and animals |
IT1162938B (en) * | 1983-08-26 | 1987-04-01 | Dino Spisni | COMPOSITION FOR THE TREATMENT OF MALIGNANT CANCERS, IN PARTICULAR ON ANIMALS |
JPS60126220A (en) * | 1983-12-09 | 1985-07-05 | Otsuka Pharmaceut Factory Inc | Nucleic acid component composition |
ES2007350A6 (en) * | 1987-05-29 | 1989-06-16 | Ganadera Union Ind Agro | Food products enriched with nucleosides and/or nucleotides and preparation thereof. |
DE58905201D1 (en) * | 1988-03-01 | 1993-09-16 | Birkmayer Walther | AGENT FOR TREATING THE PARKINSON SYNDROME. |
AT397201B (en) * | 1988-06-03 | 1994-02-25 | Birkmayer Joerg Ddr | USE OF THE ENZYME COFACTOR NADPH IN THE PRODUCTION OF A MEDICINAL PRODUCT |
-
1991
- 1991-01-24 DE DE4102240A patent/DE4102240C1/de not_active Expired - Lifetime
- 1991-12-27 JP JP3345766A patent/JP2533709B2/en not_active Expired - Fee Related
-
1992
- 1992-01-06 EP EP92250002A patent/EP0496479B1/en not_active Expired - Lifetime
- 1992-01-06 DK DK92250002.0T patent/DK0496479T3/en active
- 1992-01-06 AT AT92250002T patent/ATE112664T1/en not_active IP Right Cessation
- 1992-01-06 ES ES92250002T patent/ES2061313T3/en not_active Expired - Lifetime
- 1992-01-06 DE DE59200603T patent/DE59200603D1/en not_active Expired - Fee Related
- 1992-01-14 ZA ZA92275A patent/ZA92275B/en unknown
- 1992-01-16 CA CA002059510A patent/CA2059510C/en not_active Expired - Fee Related
- 1992-01-23 BR BR929200207A patent/BR9200207A/en not_active Application Discontinuation
- 1992-01-23 HU HU9200213A patent/HU9200213D0/en unknown
- 1992-01-23 AU AU10392/92A patent/AU663479B2/en not_active Ceased
- 1992-01-23 IE IE920198A patent/IE69861B1/en not_active IP Right Cessation
- 1992-01-23 NO NO920315A patent/NO304672B1/en not_active IP Right Cessation
- 1992-01-24 FI FI920323A patent/FI920323A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2059510C (en) | 1997-06-10 |
JP2533709B2 (en) | 1996-09-11 |
EP0496479B1 (en) | 1994-10-12 |
FI920323A0 (en) | 1992-01-24 |
NO304672B1 (en) | 1999-02-01 |
ATE112664T1 (en) | 1994-10-15 |
DE59200603D1 (en) | 1994-11-17 |
BR9200207A (en) | 1992-10-06 |
AU663479B2 (en) | 1995-10-12 |
CA2059510A1 (en) | 1992-07-25 |
ES2061313T3 (en) | 1994-12-01 |
JPH05262652A (en) | 1993-10-12 |
NO920315L (en) | 1992-07-27 |
IE920198A1 (en) | 1992-07-29 |
ZA92275B (en) | 1992-12-30 |
HU9200213D0 (en) | 1992-04-28 |
AU1039292A (en) | 1992-07-30 |
EP0496479A1 (en) | 1992-07-29 |
FI920323A (en) | 1992-07-25 |
IE69861B1 (en) | 1996-10-16 |
DE4102240C1 (en) | 1992-04-09 |
DK0496479T3 (en) | 1995-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI921183A (en) | NYA BENSOFUSIONERADE LAKTAMER, SOM FRAEMJAR FRIGIVNING AV TILLVAEXTHORMON | |
AU9062291A (en) | Formulation for treating silage | |
DK0455808T3 (en) | Procedure for Preventing Diet-Caused Carnitine Deficiency in Dogs and Cats as Pets | |
DK0973413T3 (en) | Food formulations containing lacto-N-neotetraose | |
ES2054697T3 (en) | A HYGIENIC PRODUCT, PARTICULARLY FOR THE PRESERVATION OF A DOG'S DENTURE. | |
NO920315D0 (en) | USE OF NADH AND NADPH AS ENERGY REPLACEMENT PRODUCTS | |
AU5079600A (en) | Composition comprising ozonized oils and/or other ozonized natural and/or synthetic products and their use in pharmaceutical, cosmetic, dietetic or food supplement compositions in human and veterinary medicine | |
MY131380A (en) | Fatty ingredients & products for full or partial replacement of fat in food products | |
NZ240011A (en) | Oil-in-water emulsion nutritional composition: processes for production | |
Chung et al. | A note on the dispensability of proline for weanling pigs | |
MY106830A (en) | Preparation of a cooked product having an improved preservation based on animal proteins. | |
ES553196A0 (en) | PROCEDURE FOR THE OBTAINING OF PROPIONIC ACID, AMMONIC SALT (2: 1), AND DERIVED PRODUCTS USABLE IN THE CONSERVATION OF FOOD FOR HUMAN AND ANIMAL CONSUMPTION | |
AU5744286A (en) | Potassium, sodium or calcium formate additive for inhibiting respiration of and promoting desiccation of crops | |
AU9010991A (en) | Antidepressant | |
Riopel et al. | Coronary risk factor modification in children: smoking. A statement for physicians by the Committee on Atherosclerosis and Hypertension in Childhood of the Council on Cardiovascular Disease in the Young, American Heart Association | |
EP0358527A3 (en) | Supported lactic acid | |
GB2016900A (en) | Concentrated food product | |
WO2001030984A3 (en) | Novel halotolerant and halophilic enzymes and the use of halotolerant and halophilic enzymes | |
CA2081348A1 (en) | Veterinary formulation of amoxycillin and clavulanic acid, and derivatives thereof | |
HU9200315D0 (en) | Process for the isolation of nautural lyzozyme (ec 3.2.1.17) and its use as human or veterinary medical product, or conservation product of meat and meat products | |
ES2143442A1 (en) | Application of levamisole in the manufacture of dietary products for promoting growth in fish | |
IT1283086B1 (en) | New stable and non-hygroscopic mucate(s) of L(-)carnitine and alkanoyl L(-)carnitine(s) - useful for making oral compositions for use as e.g. pharmaceutical compositions, food supplements, health foods, veterinary products and fodders | |
ECSP900654A (en) | PROCEDURE FOR THE PREPARATION OF A COOKED PRODUCT FROM LONG-TERM CONSERVATION BASED ON ANIMAL PROTEIN | |
NO944074L (en) | Microperforated film, as well as packaging bag made of the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN JULY 2003 |